Literature DB >> 19678971

El Tor cholera with severe disease: a new threat to Asia and beyond.

A K Siddique1, G B Nair, M Alam, D A Sack, A Huq, A Nizam, I M Longini, F Qadri, S M Faruque, R R Colwell, S Ahmed, A Iqbal, N A Bhuiyan, R B Sack.   

Abstract

During epidemics of cholera in two rural sites (Bakerganj and Mathbaria), a much higher proportion of patients came for treatment with severe dehydration than was seen in previous years. V. cholerae O1 isolated from these patients was found to be El Tor in its phenotype, but its cholera toxin (CT) was determined to be that of classical biotype. Whether the observed higher proportion of severe dehydration produced by the El Tor biotype was due to a shift from El Tor to classical CT or due to other factors is not clear. However, if cholera due to strains with increased severity spread to other areas where treatment facilities are limited, there are likely to be many more cholera deaths.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19678971     DOI: 10.1017/S0950268809990550

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  61 in total

1.  Cholera: lessons from haiti and beyond.

Authors:  Ana A Weil; Louise C Ivers; Jason B Harris
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes.

Authors:  J Ghosh-Banerjee; M Senoh; T Takahashi; T Hamabata; S Barman; H Koley; A K Mukhopadhyay; T Ramamurthy; S Chatterjee; M Asakura; S Yamasaki; G B Nair; Y Takeda
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  Cholera in India: an analysis of reports, 1997-2006.

Authors:  S Kanungo; B K Sah; A L Lopez; J S Sung; A M Paisley; D Sur; J D Clemens; G Balakrish Nair
Journal:  Bull World Health Organ       Date:  2010-03       Impact factor: 9.408

5.  A cholera outbreak of the Vibrio cholerae O1 El Tor variant carrying classical CtxB in northeastern Thailand in 2007.

Authors:  Kazuhisa Okada; Siriporn Chantaroj; Amonrattana Roobthaisong; Shigeyuki Hamada; Pathom Sawanpanyalert
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Occurrence in Mexico, 1998-2008, of Vibrio cholerae CTX+ El Tor carrying an additional truncated CTX prophage.

Authors:  Munirul Alam; Shah Manzur Rashed; Shahnewaj Bin Mannan; Tarequl Islam; Marcial Leonardo Lizarraga-Partida; Gabriela Delgado; Rosario Morales-Espinosa; Jose Luis Mendez; Armando Navarro; Haruo Watanabe; Makoto Ohnishi; Nur A Hasan; Anwar Huq; R Bradley Sack; Rita R Colwell; Alejandro Cravioto
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

7.  Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.

Authors:  Dennis L Chao; M Elizabeth Halloran; Ira M Longini
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 8.  Vaccines in the time of cholera.

Authors:  John D Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-11       Impact factor: 11.205

9.  Genome sequence of hybrid Vibrio cholerae O1 MJ-1236, B-33, and CIRS101 and comparative genomics with V. cholerae.

Authors:  Christopher J Grim; Nur A Hasan; Elisa Taviani; Bradd Haley; Jongsik Chun; Thomas S Brettin; David C Bruce; J Chris Detter; Cliff S Han; Olga Chertkov; Jean Challacombe; Anwar Huq; G Balakrish Nair; Rita R Colwell
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

10.  Comparative genomics of the family Vibrionaceae reveals the wide distribution of genes encoding virulence-associated proteins.

Authors:  Timothy G Lilburn; Jianying Gu; Hong Cai; Yufeng Wang
Journal:  BMC Genomics       Date:  2010-06-10       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.